StemRIM (TSE:4599) Research & Development : 円1,538 Mil (TTM As of Apr. 2024)

View and export this data going back to 2019. Start your Free Trial

What is StemRIM Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. StemRIM's Research & Development for the three months ended in Apr. 2024 was 円370 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Apr. 2024 was 円1,538 Mil.

StemRIM Research & Development Historical Data

The historical data trend for StemRIM's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

StemRIM Research & Development Chart

StemRIM Annual Data

Trend

Jul17

Jul18

Jul19

Jul20

Jul21

Jul22

Jul23

Research & Development

Get a 7-Day Free Trial

640.20

1,356.65

1,523.80

1,421.29

1,567.25

StemRIM Quarterly Data
	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24
Research & Development	Get a 7-Day Free Trial															391.66	436.21	348.28	383.97	369.90

StemRIM Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Apr. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円1,538 Mil.

StemRIM (TSE:4599) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

StemRIM Research & Development Related Terms

Thank you for viewing the detailed overview of StemRIM's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

StemRIM (TSE:4599) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » StemRIM Inc (TSE:4599) » Definitions » Research & Development

Comparable Companies

Traded in Other Exchanges

N/A

Address

7-15 Ayato Bio Incubator 3rd floor, Ayato Asagi 7-chome, Prefecture Ibaraki City, Osaka, JPN, 567-0085

Website

https://www.stemrim.com

StemRIM Inc is a biotechnology company engaged in developing regeneration-guided medicines. The business activity of the group includes research, development, manufacture, and sales of pharmaceuticals and medical devices and products such as gene therapy that activate stem cells existing in the body and induce regeneration of damaged tissue.

StemRIM (TSE:4599) Headlines

No Headlines